Tender detail
Open-house discount agreements for medicines containing guselkumab
Summary
The procurement concerns non-exclusive discount agreements for medicines containing the active ingredient guselkumab (ATC L04AC16). Agreements may be concluded at any time during the contract period from 1 January 2027 to 31 December 2028. Medicines included in the BfArM list of paediatric medicines are excluded.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.